• Antonio E Jerez Calero, Dolores Fernández Jiménez, Manuel Molina Oya, Eduardo Narbona López, and José Uberos Fernández.
• 1Neonatal Unit, Department of Pediatrics, San Cecilio University Hospital, Granada, Spain. 2Department of Haematology, San Cecilio University Hospital, Granada, Spain. 3Department of Pediatrics, San Cecilio University Hospital, Granada, Spain.
• Pediatr Crit Care Me. 2017 Nov 1; 18 (11): e569-e574.

ObjectivesTo verify the reliability and clinical benefits of the coagulation tests made by a point of care device in newborn admitted to a neonatal unit.DesignWe made a statistical comparison between results obtained by the point of care device versus conventional laboratory analysis.SettingLevel 3 neonatal unit.PatientsThirty-one infants admitted to the neonatal unit at the San Cecilio University Hospital (Granada, Spain) were recruited to this study.InterventionsAll underwent a double analytical determination: a small drop of blood was taken for analysis with a portable coagulometer (qLabs Electrometer Plus) and the rest of the blood sample was analyzed with conventional hospital laboratory equipment.Measurements And Main ResultsAccording to the linearity test performed, the measuring methods presented a good linear regression fit. Lin's concordance coefficient showed a "good" agreement for activated partial prothrombin time and international normalized ratio (>0.61) and a moderate one for prothrombin time (0.41-0.6) for the sample of newborns.ConclusionsThe portable coagulometer qLabs Electrometer Plus device has the potential to be an alternative to standard hospital coagulation autoanalyzers in a subset of patients where the amount of blood drawn can have significant risks. Our study is the first of its kind to analyze the use of this device with severely ill newborns.

22 keywords...

hide…